Clinical trials
Phase 1/2 Hemophilia A trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 2 |
| Spark Therapeutics, Inc. | 2 |
| ASC Therapeutics | 1 |
| Baxalta now part of Shire | 1 |
| Bayer | 1 |
| BioMarin Pharmaceutical | 1 |
| Bioverativ, a Sanofi company | 1 |
| Eli Lilly and Company | 1 |
| Genzyme, a Sanofi Company | 1 |
| University College, London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia A | 12 |
| Blood Coagulation Disorders | 3 |
| Blood Coagulation Disorders, Inherited | 3 |
| Coagulation Protein Disorders | 3 |
| Genetic Diseases, Inborn | 3 |
| Hematologic Diseases | 3 |
| Hemorrhagic Disorders | 3 |
| Genetic Diseases, X-Linked | 2 |
| Hemophilia B | 1 |
| Hemostatic Disorders | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.